<p>Subject valence and arousal ratings for Parkinson patients (n = 19) and healthy controls (n = 19).</p
Rating scales are increasingly the primary outcome measures in clinical trials. However, clinically ...
Introduction. Neuropsychiatric symptoms in Parkinson’s disease can be assessed by the MDS-UPDRS part...
<p>Values given as counts or as mean±SD, as appropriate. NA, not applicable. Statistically significa...
Correlations between subjective emotional ratings and clinical scores in the Parkinson’s disease gro...
<p>Baseline characteristics between healthy subjects and patients with Parkinson’s disease.</p
<p>Demographic and neuropsychological data (mean ± standard deviation) for the Parkinson's disease p...
<p>Acronyms: M: male; F: female; DD: disease duration; H&Y: Hoehn and Yahr; MMSE: Mini-Mental State ...
<div><p>A) Valence and arousal ratings for neutral and emotional sounds as a function of group (DPD ...
<p>BA = Brodmann Area; H = hemisphere, MNI coordinates (x,y,z), <i>p</i>(FWE) = corrected for family...
Comparison of the performance of the FAB-E scores between control group and Parkinson’s disease pati...
<p>f: female, m: male; TEDD: Test for Early Detection of Dementia; QADP: Questionnaire for the Asses...
Objectives: To determine whether objective (neuropsychological tests) and subjective measures (quest...
Objectives: To determine whether objective (neuropsychological tests) and subjective measures (quest...
<p>Mean (standard deviation). p values were determined in t-tests (except for the gender ratio, to w...
Copyright © 2014 Mayela Rodŕıguez-Violante et al. This is an open access article distributed under ...
Rating scales are increasingly the primary outcome measures in clinical trials. However, clinically ...
Introduction. Neuropsychiatric symptoms in Parkinson’s disease can be assessed by the MDS-UPDRS part...
<p>Values given as counts or as mean±SD, as appropriate. NA, not applicable. Statistically significa...
Correlations between subjective emotional ratings and clinical scores in the Parkinson’s disease gro...
<p>Baseline characteristics between healthy subjects and patients with Parkinson’s disease.</p
<p>Demographic and neuropsychological data (mean ± standard deviation) for the Parkinson's disease p...
<p>Acronyms: M: male; F: female; DD: disease duration; H&Y: Hoehn and Yahr; MMSE: Mini-Mental State ...
<div><p>A) Valence and arousal ratings for neutral and emotional sounds as a function of group (DPD ...
<p>BA = Brodmann Area; H = hemisphere, MNI coordinates (x,y,z), <i>p</i>(FWE) = corrected for family...
Comparison of the performance of the FAB-E scores between control group and Parkinson’s disease pati...
<p>f: female, m: male; TEDD: Test for Early Detection of Dementia; QADP: Questionnaire for the Asses...
Objectives: To determine whether objective (neuropsychological tests) and subjective measures (quest...
Objectives: To determine whether objective (neuropsychological tests) and subjective measures (quest...
<p>Mean (standard deviation). p values were determined in t-tests (except for the gender ratio, to w...
Copyright © 2014 Mayela Rodŕıguez-Violante et al. This is an open access article distributed under ...
Rating scales are increasingly the primary outcome measures in clinical trials. However, clinically ...
Introduction. Neuropsychiatric symptoms in Parkinson’s disease can be assessed by the MDS-UPDRS part...
<p>Values given as counts or as mean±SD, as appropriate. NA, not applicable. Statistically significa...
DOI
Add to ORKG